InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Shook David. Officer active across 2 companies, notably Nkarta, Inc.. Cumulatively, 11 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €53k. History available since 13 January 2023. The latest transaction was disclosed on 9 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Shook David is Chief Medical Officer at Lyell Immunopharma, Inc. He has 11 filings in total, and across the 11 sampled filings the transactions run from 2023-01-18 to 2025-06-11, with EUR 0 of buys and EUR 53,362 of sells, mainly related to Nkarta, Inc.